Schneider W J
Department of Biochemistry and Lipid, University of Alberta, Edmonton, Canada.
Biochim Biophys Acta. 1989 May 9;988(2):303-17. doi: 10.1016/0304-4157(89)90023-3.
The study of familial hypercholesterolemia at the molecular level has led to its advancement from a clinical syndrome to a fascinating experimental system. FH was first described 50 years ago by Carl Müller who concluded that the disease produces high plasma cholesterol levels and myocardial infarctions in young people, and is transmitted as an autosomal dominant trait determined by a single gene. The existence of two forms of FH, namely heterozygous and homozygous, was recognized by Khachadurian and Fredrickson and Levy much later. The value of FH as an experimental model system lies in the availability of homozygotes, because mutant genes can be studied without interference from the normal gene. The first and most important breakthrough was the realization that the defect underlying FH could be studied in cultured skin fibroblasts. Rapidly, the LDL receptor pathway was conceptualized and its dysfunction in cells from FH homozygotes was demonstrates. Isolation of the normal LDL receptor protein and studies on the biosynthesis and structure of abnormal receptors in mutant cell lines provided essential groundwork for elucidation of defects at the DNA level. The power of the experimental system, FH, became nowhere more obvious than in work that correlated structural information at the protein level with the elucidation of defined defects in the LDL receptor gene. In addition to revealing important structure-function relationships in the LDL receptor polypeptide and delineating mutational events, studies of FH have established several more general concepts. First, the tight coupling of LDL binding to its internalization suggested that endocytosis was not a non-specific process as suggested from early observations. The key finding was that LDL receptors clustered in coated pits, structures that had been described by Roth and Porter 10 years earlier. These investigators had demonstrated, in electron microscopic studies on the uptake of yolk proteins by mosquito oocytes, that coated pits pinch off from the cell surface and form coated vesicles that transport extracellular fluid into the cell. Studies on the LDL receptor system showed directly that receptor clustering in coated pits is the essential event in this kind of endocytosis, and thus established receptor-mediated endocytosis as a distinct mechanism for the transport of macromolecules across the plasma membrane. Subsequently, many additional systems of receptor-mediated endocytosis have been defined, and variations of the overall pathway have been described.(ABSTRACT TRUNCATED AT 400 WORDS)
在分子水平上对家族性高胆固醇血症的研究,已使其从一种临床综合征发展成为一个引人入胜的实验系统。50年前卡尔·米勒首次描述了家族性高胆固醇血症,他得出结论,该疾病会导致年轻人血浆胆固醇水平升高和心肌梗死,并且作为由单个基因决定的常染色体显性性状进行遗传。卡查杜里安、弗雷德里克森和利维很久之后才认识到家族性高胆固醇血症存在两种形式,即杂合子和纯合子。家族性高胆固醇血症作为实验模型系统的价值在于纯合子的可得性,因为可以在不受正常基因干扰的情况下研究突变基因。第一个也是最重要的突破是认识到可以在培养的皮肤成纤维细胞中研究家族性高胆固醇血症的潜在缺陷。很快,低密度脂蛋白受体途径得以概念化,并且在家族性高胆固醇血症纯合子的细胞中证明了其功能障碍。正常低密度脂蛋白受体蛋白的分离以及对突变细胞系中异常受体的生物合成和结构的研究,为在DNA水平阐明缺陷提供了重要的基础。家族性高胆固醇血症这个实验系统的强大之处,在将蛋白质水平的结构信息与低密度脂蛋白受体基因中明确缺陷的阐明相关联的研究中体现得最为明显。除了揭示低密度脂蛋白受体多肽中重要的结构 - 功能关系以及描绘突变事件外,对家族性高胆固醇血症的研究还确立了几个更普遍的概念。首先,低密度脂蛋白结合与其内化的紧密耦合表明,内吞作用并非如早期观察所暗示的那样是一个非特异性过程。关键发现是低密度脂蛋白受体聚集在被膜小窝中,这是罗斯和波特10年前描述过的结构。这些研究人员在对蚊子卵母细胞摄取卵黄蛋白的电子显微镜研究中表明,被膜小窝从细胞表面脱离并形成将细胞外液转运到细胞内的被膜小泡。对低密度脂蛋白受体系统的研究直接表明,受体在被膜小窝中的聚集是这种内吞作用中的关键事件,从而确立了受体介导的内吞作用作为大分子跨质膜转运的一种独特机制。随后,定义了许多其他受体介导的内吞作用系统,并描述了整个途径的变体。(摘要截选至400字)